Chemotherapy efficacy is also limited by the low brain/tumor accessibility due to multidrug resistance transporters (MDRs), Pgp (P-glycoprotein), and BCRP (breast cancer resistance protein) expressed at the blood–brain barrier and in glioblastoma cells [212,213]. Here, ABCG2 is linked to glioblastoma.